In our results, PEPCK (LinJ.27.1710) was identified as a potential target for Staurosporine compounds, protein kinase inhibitors also previously inferred with potential interaction for other proteins in the dataset of potential targets in Leishmania species, that have an effect on leishmaniasis preventing the growth of parasitic cells and reducing their virulence (Becker and Jaffe, 1997; Basmaciyan et al., 2018; Omura et al., 2018). Here, PCK2 is linked to leishmaniasis.